| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |